Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 10-том 1-нөмір (2025)

HIP FRACTURE, DIAGNOSIS, SURGICAL TREATMENT, REHABILITATION, THROMBOEMBOLIC PROPHYLAXIS, BISPHOSPHONATES, FALL PREVENTION

КАРШИБАЕВ Абдувахоб Жамбоевич, МЕЛИБАЕВ Салимжон Таштанович, НОМАЗОВ Олим Эргаш Угли, ЖАЛИЛОВ Хусан Мухитдинович

Дереккөзден оқу PDF

Аңдатпа

Introduction. Hip fractures represent a major challenge in orthopedic trauma due to their high morbidity and mortality, particularly among elderly individuals. Women account for approximately 80% of cases, with an average patient age of 80 years. Key risk factors include falls, decreased bone mineral density, reduced physical activity levels, and prolonged use of certain medications. Methods. Clinical evaluation of hip fractures typically reveals groin pain and an inability to bear weight on the affected limb. In displaced fractures, physical examination often shows external rotation, abduction, and limb shortening. Standard diagnostic imaging consists of anteroposterior pelvic radiographs and cross-table lateral hip views. In cases where an occult fracture is suspected despite normal radiographic findings, magnetic resonance imaging (MRI) is recommended for further assessment. Results. Surgical intervention remains the primary treatment for most hip fractures, with the choice of procedure determined by the consulting orthopedic surgeon. Common surgical approaches include osteosynthesis and hip arthroplasty. Preoperative prophylactic antibiotics, particularly targeting Staphylococcus aureus, are administered to reduce the risk of infections. Additionally, venous thromboembolism prophylaxis, preferably with low-molecular-weight heparin, is recommended. Conclusion. Hip fractures pose a significant health concern, necessitating prompt diagnosis and a multidisciplinary treatment approach. A combination of surgical repair, prophylactic measures, structured rehabilitation, and fall prevention strategies is essential for improving patient survival rates and enhancing quality of life in this vulnerable population.

перелом шейки бедра, диагностика, хирургическое лечение, реабилитация, тромбоэмболическая профилактика, бисфосфонаты, профилактика паденийHip fracture, diagnosis, surgical treatment, rehabilitation, thromboembolic prophylaxis, bisphosphonates, fall preventionSon suyagi sinishi, tashxis, jarrohlik davolash, reabilitatsiya, tromboemboliyani oldini olish, bifosfonatlar, yiqilishning oldini olish

Метадеректер дереккөзі: журналдың OAI-PMH архиві · Sindex толық мәтінді сақтамайды, дереккөзге сілтеме береді.

Дәйексөз алу

APA 7
КАРШИБАЕВ Абдувахоб Жамбоевич, МЕЛИБАЕВ Салимжон Таштанович, НОМАЗОВ Олим Эргаш Угли & ЖАЛИЛОВ Хусан Мухитдинович (2025). HIP FRACTURE, DIAGNOSIS, SURGICAL TREATMENT, REHABILITATION, THROMBOEMBOLIC PROPHYLAXIS, BISPHOSPHONATES, FALL PREVENTION. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(1).
GOST R 7.0.5
КАРШИБАЕВ Абдувахоб Жамбоевич, МЕЛИБАЕВ Салимжон Таштанович, НОМАЗОВ Олим Эргаш Угли, ЖАЛИЛОВ Хусан Мухитдинович HIP FRACTURE, DIAGNOSIS, SURGICAL TREATMENT, REHABILITATION, THROMBOEMBOLIC PROPHYLAXIS, BISPHOSPHONATES, FALL PREVENTION // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. 2025. Т. 10. № 1.
BibTeX
@article{жамбоевич2025,
  author  = {КАРШИБАЕВ Абдувахоб Жамбоевич and МЕЛИБАЕВ Салимжон Таштанович and НОМАЗОВ Олим Эргаш Угли and ЖАЛИЛОВ Хусан Мухитдинович},
  title   = {HIP FRACTURE, DIAGNOSIS, SURGICAL TREATMENT, REHABILITATION, THROMBOEMBOLIC PROPHYLAXIS, BISPHOSPHONATES, FALL PREVENTION},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year    = {2025},
  volume  = {10},
  number  = {1}
}
RIS
TY  - JOUR
AU  - КАРШИБАЕВ Абдувахоб Жамбоевич
AU  - МЕЛИБАЕВ Салимжон Таштанович
AU  - НОМАЗОВ Олим Эргаш Угли
AU  - ЖАЛИЛОВ Хусан Мухитдинович
TI  - HIP FRACTURE, DIAGNOSIS, SURGICAL TREATMENT, REHABILITATION, THROMBOEMBOLIC PROPHYLAXIS, BISPHOSPHONATES, FALL PREVENTION
JO  - Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
PY  - 2025
VL  - 10
IS  - 1
ER  -